Intrinsiqq
Codexis Inc. logo

Codexis Inc. (CDXS) Insider Trading

Last 12 months

Insiders sold $68k and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. The last open-market buy by an executive or director was in Sep 2023.

Net open-market
−$68k
0 buys · 10 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 5
executives and directors
Last open-market buy
Sep 2023
Sep 11, 2023

Get an email when CDXS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 12No plan
    Georgia Erbez
    See Remarks · sold 6,335 at $1.36
    $9k
    9.5% of stake
  • Oct 12No plan
    Alison Moore
    President and CEO · sold 6,335 at $1.36
    $9k
    2.5% of stake
  • Jun 11No plan
    Raymond De Vre
    Director · sold 2,605 at $2.37
    $6k
    3.0% of stake
  • Feb 24No plan
    Stefan Lutz
    Chief Scientific Officer · sold 5,862 at $1.13
    $7k
    4.3% of stake
  • Feb 6No plan
    Stefan Lutz
    Chief Scientific Officer · sold 2,492 at $1.31
    $3k
    1.8% of stake
  • Feb 6No plan
    Georgia Erbez
    See Remarks · sold 3,826 at $1.31
    $5k
    5.4% of stake
  • Feb 6No plan
    Alison Moore
    President and CEO · sold 3,826 at $1.31
    $5k
    1.5% of stake
  • Jan 7No plan
    Stefan Lutz
    CSO · sold 4,685 at $1.70
    $8k
    3.3% of stake
  • Nov 26, 2025 – Dec 1, 2025No plan
    Opaleye Management Inc.
    Large holder · sold 514,341 at avg $1.71
    $878k
    4.8% of stake
  • Nov 21, 2025No plan
    Dennis P Wolf
    Director · sold 8,952 at $1.56
    $14k
    6.1% of stake
  • Nov 12, 2025No plan
    Opaleye Management Inc.
    Large holder · sold 1,082,459 at avg $1.94
    $2.1M
    11% of stake
  • Nov 7, 2025 – Nov 11, 2025No plan
    Opaleye Management Inc.
    Large holder · sold 1,063,211 at avg $1.76
    $1.87M
    8.3% of stake
  • Nov 11, 2025No plan
    Raymond De Vre
    Director · sold 1,413 at $1.74
    $2k
    1.6% of stake
  • Oct 13, 2025No plan
    Alison Moore
    Chief Technical Officer · sold 6,239 at $2.51
    $16k
    3.6% of stake
  • Oct 13, 2025No plan
    Georgia Erbez
    Chief Financial Officer · sold 6,239 at $2.51
    $16k
    8.1% of stake
  • Jul 31, 2025 – Aug 4, 2025
    Opaleye Management Inc.
    Large holder · bought 85,000 at avg $2.68
    $228k
    0.7% of stake
  • Jul 29, 2025 – Jul 30, 2025
    Opaleye Management Inc.
    Large holder · bought 10,000 at avg $2.82
    $28k
    <0.1% of stake
  • Jul 18, 2025
    Opaleye Management Inc.
    Large holder · bought 100,000 at $2.82
    $282k
    0.8% of stake
  • Jun 27, 2025
    Opaleye Management Inc.
    Large holder · bought 100,000 at $2.39
    $239k
    0.8% of stake
  • Jun 12, 2025 – Jun 16, 2025
    Opaleye Management Inc.
    Large holder · bought 250,000 at avg $2.24
    $560k
    2.0% of stake
  • May 23, 2025 – May 28, 2025
    Opaleye Management Inc.
    Large holder · bought 2,325,000 at avg $2.36
    $5.49M
    23% of stake
  • Apr 30, 2025 – May 1, 2025
    Opaleye Management Inc.
    Large holder · bought 45,000 at avg $2.31
    $104k
    0.5% of stake
  • Apr 25, 2025
    Opaleye Management Inc.
    Large holder · bought 25,000 at $2.24
    $56k
    0.3% of stake
  • Apr 15, 2025 – Apr 17, 2025
    Opaleye Management Inc.
    Large holder · bought 140,000 at avg $2.14
    $299k
    1.4% of stake
  • Apr 8, 2025
    Opaleye Management Inc.
    Large holder · bought 100,000 at $1.98
    $198k
    1.0% of stake
  • Apr 1, 2025 – Apr 3, 2025
    Opaleye Management Inc.
    Large holder · bought 115,000 at avg $2.36
    $272k
    1.2% of stake
  • Mar 20, 2025 – Mar 21, 2025
    Opaleye Management Inc.
    Large holder · bought 92,930 at avg $2.54
    $236k
    1.0% of stake
  • Mar 13, 2025
    Opaleye Management Inc.
    Large holder · bought 85,000 at $2.54
    $216k
    0.9% of stake
  • Mar 6, 2025
    Opaleye Management Inc.
    Large holder · bought 100,000 at $2.61
    $261k
    1.1% of stake
  • Mar 4, 2025 – Mar 5, 2025
    Opaleye Management Inc.
    Large holder · bought 65,000 at avg $2.65
    $172k
    0.7% of stake
  • Feb 28, 2025 – Mar 3, 2025
    Opaleye Management Inc.
    Large holder · bought 195,000 at avg $2.95
    $575k
    2.2% of stake
  • Feb 10, 2025 – Feb 12, 2025
    Opaleye Management Inc.
    Large holder · bought 50,000 at avg $4.11
    $205k
    0.6% of stake
  • Jan 30, 2025 – Jan 31, 2025
    Opaleye Management Inc.
    Large holder · bought 65,000 at avg $4.35
    $283k
    0.8% of stake
  • Dec 30, 2024 – Dec 31, 2024
    Opaleye Management Inc.
    Large holder · bought 45,000 at avg $4.69
    $211k
    0.5% of stake
  • Oct 25, 2024
    Opaleye Management Inc.
    Large holder · bought 25,000 at $2.91
    $73k
    0.3% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CDXS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Industrial Organic Chemicals

Spot a number that looks wrong? Check it in CDXS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CDXS

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.